RFK Jr looks to alter rare disease regulation by fast-tracking drug approvals
Pharmaceutical Technology
JUNE 6, 2025
In one of the fierier remarks from the roundtable, RFK Jr said: “At every level, doctors, other providers, our hospitals, the pharmaceutical companies, the insurance companies, all make money by keeping us sick. Please check your inbox to download the Whitepaper. You will receive an email shortly.
Let's personalize your content